SB

Steven P. Braithwaite

AL Alkahest: 9 patents #1 of 23Top 5%
RJ Rutgers, The State University Of New Jersey: 3 patents #255 of 1,498Top 20%
Stanford University: 1 patents #2,251 of 5,197Top 45%
Overall (All Time): #410,136 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11413308 Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami 2022-08-16
11382907 Methods and compositions for treating aging-associated impairments using CCR3-inhibitors S. Sakura Minami, Karoly Nikolich 2022-07-12
11040068 Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Meghan Kerrisk Campbell, Eva Czirr, Ian Gallager, Nina Huber, Sam Jackson +1 more 2021-06-22
10905717 Blood plasma and plasma fractions as therapy for tumor growth and progression S. Sakura Minami, Joseph McCracken 2021-02-02
10905779 Methods for screening human blood products comprising plasma using immunocompromised rodent models Saul A. Villeda, Anton Wyss-Coray 2021-02-02
10874692 Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami 2020-12-29
10736889 Method of treating dyskinesia M. Maral Mouradian, Michael Voronkov 2020-08-11
10525107 Blood plasma fractions as a treatment for aging-associated cognitive disorders David Bell, Ian Gallager, S. Sakura Minami, Vu Cao Dang, Joe McCracken +1 more 2020-01-07
10357513 Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami 2019-07-23
10245285 Blood plasma and plasma fractions as therapy for tumor growth and progression S. Sakura Minami, Joseph McCracken 2019-04-02
9918980 Method of treating dyskinesia M. Maral Mouradian, Michael Voronkov 2018-03-20
9289423 Method of treating dyskinesia Mary Maral Mouradian, Michael Voronkov 2016-03-22